Trials / Terminated
TerminatedNCT02366988
The PASTEC Study: Endoscopic Stenting Versus Surgery for the Treatment of Bile Duct Stricture in Chronic Pancreatitis
Phase 3 Prospective, Multicentric Randomized Study of Endoscopic Versus Surgical Treatment of Bile Duct Stricture in Chronic Pancreatitis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Biliary obstruction complicates the course of chronic pancreatitis in 3%-23% of patients and in these cases, endoscopy and surgery are the treatment modalities of choice. Morbid-mortality of these procedures is similar and physicians face the decision between endoscopy and surgery for this group of patients, with no randomized controlled trial available comparing these procedures. The PASTEC trial is a multicenter, phase III, randomized, comparing the effectiveness of surgical and endoscopic interventions in the management of bile duct stricture for chronic pancreatitis. The primary end point is 18-months normalization of serum alkaline phosphatase. Secondary end points are morbid-mortality rate, quality of life, numbers of endoscopic or surgical procedures, length of stay. Eighty-six patients need to be included.
Detailed description
This study is planned to last for 4 years, with a 2-year inclusion period and a 2-year follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endoscopic Biliary Stenting | Endoscopic probe self-expandable metallic covered stent Biliary stent will be left in place for 6 months |
| PROCEDURE | Surgical treatment Bilio-enteric anastomosis | Bilio-enteric anastomosis including Whipple, Frey or Beger procedure, double or triple derivation |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2015-02-20
- Last updated
- 2018-06-21
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02366988. Inclusion in this directory is not an endorsement.